IN2012MN02925A - - Google Patents
Info
- Publication number
- IN2012MN02925A IN2012MN02925A IN2925MUN2012A IN2012MN02925A IN 2012MN02925 A IN2012MN02925 A IN 2012MN02925A IN 2925MUN2012 A IN2925MUN2012 A IN 2925MUN2012A IN 2012MN02925 A IN2012MN02925 A IN 2012MN02925A
- Authority
- IN
- India
- Prior art keywords
- prulifloxacin
- methyl
- oxo
- crystalline
- relates
- Prior art date
Links
- PWNMXPDKBYZCOO-UHFFFAOYSA-N Prulifloxacin Chemical compound C1=C2N3C(C)SC3=C(C(O)=O)C(=O)C2=CC(F)=C1N(CC1)CCN1CC=1OC(=O)OC=1C PWNMXPDKBYZCOO-UHFFFAOYSA-N 0.000 abstract 4
- 229960001224 prulifloxacin Drugs 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2925MUN2012 IN2012MN02925A (de) | 2010-06-30 | 2011-06-30 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1920MU2010 | 2010-06-30 | ||
IN2925MUN2012 IN2012MN02925A (de) | 2010-06-30 | 2011-06-30 | |
PCT/GB2011/000982 WO2012001357A1 (en) | 2010-06-30 | 2011-06-30 | Crystalline form of prulifloxacin and processes for its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012MN02925A true IN2012MN02925A (de) | 2015-05-22 |
Family
ID=44454717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2925MUN2012 IN2012MN02925A (de) | 2010-06-30 | 2011-06-30 |
Country Status (3)
Country | Link |
---|---|
GB (1) | GB2498107A (de) |
IN (1) | IN2012MN02925A (de) |
WO (1) | WO2012001357A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102718781B (zh) * | 2012-05-08 | 2015-04-29 | 四川科伦药物研究有限公司 | 一种普卢利沙星的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0751579B2 (ja) * | 1987-11-07 | 1995-06-05 | 日本新薬株式会社 | キノリンカルボン酸誘導体 |
CA2523854C (en) | 2003-04-30 | 2012-10-16 | Nippon Shinyaku Co., Ltd. | Crystals of quinolinecarboxylic acid derivative solvate |
EP2081940A4 (de) | 2006-11-17 | 2009-12-02 | Hetero Drugs Ltd | Verfahren zur herstellung von prulifloxacin unter einsatz neuer zwischenprodukte |
EP2148883A1 (de) | 2007-03-14 | 2010-02-03 | Ranbaxy Laboratories Limited | Verfahren zur herstellung von reinem prulifloxacin |
US20100113783A1 (en) | 2007-03-14 | 2010-05-06 | Ranbaxy Laboratories Limited | Process for the preparation of crystals of prulifloxacin |
WO2010084508A2 (en) | 2009-01-14 | 2010-07-29 | Elder Pharmaceuticals Ltd. | Process for the preparation of type i, type ii and type iii crystalline prulifloxacin |
-
2011
- 2011-06-30 IN IN2925MUN2012 patent/IN2012MN02925A/en unknown
- 2011-06-30 WO PCT/GB2011/000982 patent/WO2012001357A1/en active Application Filing
- 2011-06-30 GB GB1301307.3A patent/GB2498107A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB201301307D0 (en) | 2013-03-06 |
GB2498107A (en) | 2013-07-03 |
WO2012001357A1 (en) | 2012-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP201706774B (en) | Heterocyclyl compounds | |
MD20140084A2 (en) | New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same | |
MY198066A (en) | Method for the preparation of (4s)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient | |
IN2014MN02598A (de) | ||
WO2011121418A9 (en) | 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists | |
MX2012014017A (es) | Derivados de heteroaril imidazolona como inhibidores de jak. | |
MY183312A (en) | Pharmaceutical formulation | |
IN2014KN00948A (de) | ||
WO2014045162A8 (en) | ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-AMINE COMPOUNDS | |
MX361618B (es) | Formulaciones farmacéuticas que comprenden derivados de nitrocatecol y métodos para hacer las mismas. | |
WO2010092090A3 (en) | Novel salts of sitagliptin | |
MX2011010415A (es) | Formulaciones farmaceuticas que comprenden derivados de nitrocatecol y metodos para hacer las mismas. | |
WO2013004995A8 (en) | Pyrimidinone compounds and their use | |
WO2012025944A3 (en) | Sitagliptin, salts and polymorphs thereof | |
MX348228B (es) | Cristal de derivados de 6,7-insaturado-7-carbamoil morfinano y metodo para producir el mismo. | |
MX346248B (es) | Derivados de [1,2,3]triazol[4,5-d]pirimidina como agonistas de los agonistas del receptor canabinoide 2. | |
MX2015014025A (es) | Derivados de n-(2,3-dihidro-1h-pirrolo[2,3,b]piridin-5-il)-4-quina zolinamina y n-(2,3-dihidro-1h-indol-5-il)-4-quinazolinamina novedosos como inhibidores de perk. | |
ZA201500362B (en) | Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient | |
WO2013128379A3 (en) | Crystalline polymorphic forms of linagliptin | |
WO2014062838A3 (en) | Pkm2 modulators and methods for their use | |
SA112330457B1 (ar) | مشتقات فينيل- ايزواوكسازول وعملية تحضيرها | |
IN2012DN01292A (de) | ||
EA201291014A1 (ru) | Трициклическое индазольное соединение, способ его получения и содержащая его фармацевтическая композиция | |
WO2011050054A3 (en) | Coumarin compounds as receptor modulators with therapeutic utility | |
MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids |